STAGE 02 · CONCEPT

Shape and select the concept

Compare credible solutions, select the best product concept, and connect clinical value to feasibility and intellectual property.

Typical horizon2–6 months
Common capitalBootstrapping · pre-seed · university grants
Illustrative spendOften $50K–$300K

How to know you are here

The clinical need and intended user are reasonably clear
Several solution concepts have been compared
The team is defining architecture, claims, and protectable elements

What must be managed together

Evidence

Concept comparison, expert review, early modeling, mock-ups, and initial user feedback.

Regulatory

Refine intended use, device classification, pathway hypothesis, and applicable standards.

Capital

Bootstrapping · pre-seed · university grants. Often $50K–$300K.

Priorities for the next 90 days

  1. 01

    Compare alternative concepts against clinical and engineering criteria

  2. 02

    Create the initial system architecture and product requirements

  3. 03

    Complete prior-art and freedom-to-operate screening

  4. 04

    Test the concept with representative users before detailed engineering

Required outputs

  • Concept-selection rationale
  • System architecture v0.1
  • Invention disclosure or provisional-IP plan
  • Regulatory pathway hypothesis

Common failure modes

  • Selecting the most elegant technology rather than the best clinical fit
  • Premature design lock
  • Missing an enabling patent or regulatory constraint
THE DECISION GATE

Is the selected concept clinically useful, technically feasible, differentiated, and worth protecting?

Do not advance because time or money has been spent. Advance when the evidence supports the decision.

NEED A COMPANY-SPECIFIC ROADMAP?

Turn this orientation into a milestone plan.

SECUIA can connect product, evidence, regulatory, usability, and financing decisions around your actual technology.

Call SECUIA